Concepedia

S. Pettit

SP

Statistics

Publications

3

Citations

156

H-Index

3

Active since

2015

Affiliations

Gilead Sciences (United States)(Current)

Cypralis (United Kingdom)

S. Pettit is an author at Gilead Sciences (United States) specializing in medicinal chemistry, pharmacy, and drug discovery.

Publications per year

2015–2018

3

Publications

3

Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle

Richard L. Mackman, Victoria A. Steadman, David K. Dean et al. · Journal of Medicinal Chemistry · 2018 · 78 citations · Full text

, , +17

Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A

Victoria A. Steadman, S. Pettit, Karine G. Poullennec et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

, , +17

Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2

Douglas R. Houston, Li-Hsuan Yen, S. Pettit et al. · PLoS ONE · 2015 · 20 citations · Full text

, , +13

1–3 of 3